Nitric oxide and redox signaling in allergic airway inflammation

Antioxidants and Redox Signaling

Volumn 7, Issue 1-2, 2005, Pages 129-143

  Reynaert, Niki L ^a,b   Ckless, Karina ^a   Wouters, Emiel F M ^b   Van Der Vliet, Albert ^a   Janssen Heininger, Yvonne M W ^a,b  

^a UNIVERSITY OF VERMONT   (United States)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; AMINO ACID TRANSPORTER; ARGININE; CASPASE 3; CITRULLINE; COLLAGEN; CYCLIC GMP; EOSINOPHIL PEROXIDASE; GELATINASE B; GUANYLATE CYCLASE; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MYELOPEROXIDASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; O NITROSOETHANOL; ORNITHINE; PEROXYNITRITE; PROTEIN P21; PROTEIN P50; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RYANODINE RECEPTOR; S NITROSOGLUTATHIONE; S NITROSOTHIOL; THIOREDOXIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AEROBIC METABOLISM; APOPTOSIS; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; EXPIRED AIR; HUMAN; LUNG LAVAGE; NITRATION; NITROSATION; NITROSYLATION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; REVIEW; SIGNAL TRANSDUCTION; TRACHEA;

APOPTOSIS; ARGININE; ASTHMA; HUMANS; INFLAMMATION; LUNG; MODELS, BIOLOGICAL; NF-KAPPA B; NITRIC OXIDE; OXIDATION-REDUCTION; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; RESPIRATORY SYSTEM; S-NITROSOTHIOLS; SIGNAL TRANSDUCTION; TYROSINE;

EID: 13244255209     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2005.7.129     Document Type: Review

References (170)

1. Abu-Soud HM, Khassawneh MY, Sohn JT, Murray P, Haxhiu MA, and Hazen SL. Peroxidases inhibit nitric oxide (NO) dependent bronchodilation: development of a model describing NO-peroxidase interactions. Biochemistry 40: 11866-11875, 2001.
2. Akaike T, Noguchi Y, Ijiri S, Setoguchi K, Suga M, Zheng YM, Dietzschold B, and Maeda H. Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc Natl Acad Sci U S A 93: 2448-2453, 1996.
3. Andersson C, Gaston B, and Roomans GM. S-Nitrosoglutathione induces functional DeltaF508-CFTR in airway epithelial cells. Biochem Biophys Res Commun 297: 552-557, 2002.
4. Andreadis AA, Hazen SL, Comhair SA, and Erzurum SC. Oxidative and nitrosative events in asthma. Free Radic Biol Med 35: 213-225, 2003.
5. Anest V, Hanson JL, Cogswell PC, Steinbrecher KA, Strahl BD, and Baldwin AS. A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression. Nature 423: 659-663, 2003.
6. Ascenzi P, Colasanti M, Persichini T, Muolo M, Polticelli F, Venturini G, Bordo D, and Bolognesi M. Re-evaluation of amino acid sequence and structural consensus rules for cysteine-nitric oxide reactivity. Biol Chem 381: 623-627, 2000.
7. Baldus S, Eiserich JP, Mani A, Castro L, Figueroa M, Chumley P, Ma W, Tousson A, White CR, Bullard DC, Brennan ML, Lusis AJ, Moore KP, and Freeman BA. Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J Clin Invest 108: 1759-1770, 2001.
8. Bender AT, Demady DR, and Osawa Y. Ubiquitination of neuronal nitric-oxide synthase in vitro and in vivo. J Biol Chem 275: 17407-17411, 2000.
9. Berlett BS, Levine RL, and Stadtman ER. Carbon dioxide stimulates peroxynitrite-mediated nitration of tyrosine residues and inhibits oxidation of methionine residues of glutamine synthetase: both modifications mimic effects of adenylylation. Proc Natl Acad Sci U S A 95: 2784-2789, 1998.
10. Birrell MA, McCluskie K, Haddad el B, Battram CH, Webber SE, Foster ML, Yacoub MH, and Belvisi MG. Pharmacological assessment of the nitric-oxide synthase isoform involved in eosinophilic inflammation in a rat model of sephadex-induced airway inflammation. J Pharmacol Exp Ther 304: 1285-1291, 2003.
11. Broillet MC, S-nitrosylation of proteins. Cell Mol Life Sci 55: 1036-1042, 1999.
12. Brookes, PS, Levonen AL, Shiva S, Sarti P, and Darley-Usmar VM. Mitochondria: regulators of signal transduction by reactive oxygen and nitrogen species. Free Radic Biol Med 33: 755-764, 2002.
13. Bucchieri, F, Puddicombe SM, Lordan JL, Richter A, Buchanan D, Wilson SJ, Ward J, Zummo G, Howarth PH, Djukanovic R, Holgate ST, and Davies DE. Asthmatic bronchial epithelium is more susceptible to oxidant-induced apoptosis. Am J Respir Cell Mol Biol 27: 179-185, 2002.
14. Butt E, Bernhardt M, Smolenski A, Kotsonis P, Frohlich LG, Sickmann A, Meyer HE, Lohmann SM, and Schmidt HH. Endothelial nitric-oxide synthase (type III) is activated and becomes calcium independent upon phosphorylation by cyclic nucleotide-dependent protein kinases. J Biol Chem 275: 5179-5187, 2000.
15. Chen ZP, Mitchelhill KI, Michell BJ, Stapleton D, Rodriguez-Crespo I, Witters LA, Power DA, Ortiz de Montellano PR, and Kemp BE. AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 443: 285-289, 1999.
16. Clancy RM, Leszczynska-Piziak J, and Abramson SB. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 90: 1116-1121, 1992.
17. Connelly L, Palacios-Callender M, Ameixa C, Moncada S, and Hobbs AJ. Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide. J Immunol 166: 3873-3881, 2001.
18. Cook S, Vollenweider P, Menard B, Egli M, Nicod P, and Scherrer U. Increased eNO and pulmonary iNOS expression in eNOS null mice. Eur Respir J 21: 770-773, 2003.
19. Coope HJ, Atkinson PG, Huhse B, Belich M, Janzen J, Holman MJ, Klaus GG, Johnston LH, and Ley SC. CD40 regulates the processing of NF-kappaB2 p100 to p52. EMBO J 21: 5375-5385, 2002.
20. Csoma Z, Bush A, Wilson NM, Donnelly L, Balint B, Barnes PJ, and Kharitonov SA. Nitric oxide metabolites are not reduced in exhaled breath condensate of patients with primary ciliary dyskinesia. Chest 124: 633-638, 2003.
21. 2+ channel Cav1.2. Science 293: 98-101, 2001.
22. Davis IC, Zhu S, Sampson JB, Crow JP, and Matalon S. Inhibition of human surfactant protein A function by oxidation intermediates of nitrite. Free Radic Biol Med 33: 1703-1713, 2002.
23. Delgado-Esteban M, Almeida A, and Medina JM. Tetrahydrobiopterin deficiency increases neuronal vulnerability to hypoxia. J Neurochem 82: 1148-1159, 2002.
24. De Sanctis GT, MacLean JA, Hamada K, Mehta S, Scott JA, Jiao A, Yandava CN, Kobzik L, Wolyniec WW, Fabian AJ, Venugopal CS, Grasemann H, Huang PL, and Drazen JM. Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma. J Exp Med 189: 1621-1630, 1999.
25. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, and Zeiherv AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399: 601-605, 1999.
26. Druilhe A, Letuve S, and Pretolani M. Glucocorticoid-induced apoptosis in human eosinophils: mechanisms of action. Apoptosis 8: 481-495, 2003.
27. Duguet A, Iijima H, Eum SY, Hamid Q, and Eidelman DH. Eosinophil peroxidase mediates protein nitration in allergic airway inflammation in mice. Am J Respir Crit Care Med 164: 1119-1126, 2001.
28. Duncan CJ, Lawrie A, Blaylock MG, Douglas JG, and Walsh GM. Reduced eosinophil apoptosis in induced sputum correlates with asthma severity. Eur Respir J 22: 484-490, 2003.
29. Dupont LJ, Demedts MG, and Verleden GM. Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma. Chest 123: 751-756, 2003.
30. Eiserich JP, Estevez AG, Bamberg TV, Ye YZ, Chumley PH, Beckman JS, and Freeman BA. Microtubule dysfunction by posttranslational nitrotyrosination of alpha-tubulin: a nitric oxide-dependent mechanism of cellular injury. Proc Natl Acad Sci U S A 96: 6365-6370, 1999.
31. Endo M, Oyadomari S, Terasaki Y, Takeya M, Suga M, Mori M, and Gotoh T. Induction of arginase I and II in bleomycin-induced fibrosis of mouse lung. Am J Physiol Lung Cell Mol Physiol 285: L313-L321, 2003.
32. Eu JP, Liu L, Zeng M, and Stamler JS. An apoptotic model for nitrosative stress. Biochemistry 39: 1040-1047, 2000.
33. Eynott PR, Paavolainen N, Groneberg DA, Noble A, Salmon M, Nath P, Leung SY, and Chung KF. Role of nitric oxide in chronic allergen-induced airway cell proliferation and inflammation. J Pharmacol Exp Ther 304: 22-29, 2003.
34. Fang FC, Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 99: 2818-2825, 1997.
35. Fang K, Johns R, Macdonald T, Kinter M, and Gaston B. S-nitrosoglutathione breakdown prevents airway smooth muscle relaxation in the guinea pig. Am J Physiol Lung Cell Mol Physiol 279: L716-L721, 2000.
36. Feder LS, Stelts D, Chapman RW, Manfra D, Crawley Y, Jones H, Minnicozzi M, Fernandez X, Paster T, Egan RW, Kreutner W, and Kung TT. Role of nitric oxide on eosinophilic lung inflammation in allergic mice. Am J Respir Cell Mol Biol 17: 436-442, 1997.
37. Feletou M, Lonchampt M, Coge F, Galizzi JP, Bassoullet C, Merial C, Robineau P, Boutin JA, Huang PL, Vanhoutte PM, and Canet E. Regulation of murine airway responsiveness by endothelial nitric oxide synthase. Am J Physiol Lung Cell Mol Physiol 281: L258-L267, 2001.
38. Fortenberry JD, Owens ML, Brown MR, Atkinson D, and Brown LA. Exogenous nitric oxide enhances neutrophil cell death and DNA fragmentation. Am J Respir Cell Mol Biol 18: 421-428, 1998.
39. Fortenberry JD, Owens ML, and Brown LA. S-Nitrosoglutathione enhances neutrophil DNA fragmentation and cell death. Am J Physiol 276(3 Pt 1): L435-L442, 1999.
40. Fries DM, Paxinou E, Themistocleous M, Swanberg E, Griendling KK, Salvemini D, Slot JW, Heijnen HF, Hazen SL, and Ischiropoulos H. Expression of inducible nitric-oxide synthase and intracellular protein tyrosine nitration in vascular smooth muscle cells: role of reactive oxygen species. J Biol Chem 278: 22901-22907, 2003.
41. Fujihara S, Ward C, Dransfield I, Hay RT, Uings IJ, Hayes B, Farrow SN, Haslett C, and Rossi AG. Inhibition of nuclear factor-kappaB activation un-masks the ability of TNF-alpha to induce human eosinophil apoptosis. Eur J Immunol 32: 457-466, 2002.
42. Fulton D, Gratton JP, and Sessa WC. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? J Pharmacol Exp Ther 299: 818-824, 2001.
43. Gaston B, Drazen JM, Jansen A, Sugarbaker DA, Loscalzo J, Richards W, and Stamler JS. Relaxation of human bronchial smooth muscle by S-nitrosothiols in vitro. J Pharmacol Exp Ther 268: 978-984, 1994.
44. Gaston B, Drazen JM, Loscalzo J, and Stamler JS. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 149(2 Pt 1): 538-551, 1994.
45. Gaston B, Sears S, Woods J, Hunt J, Ponaman M, McMahon T, and Stamler JS. Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure. Lancet 351: 1317-1319, 1998.
46. Gath I, Ebert J, Godtel-Armbrust U, Ross R, Reske-Kunz AB, and Forstermann U. NO synthase II in mouse skeletal muscle is associated with caveolin 3. Biochem J 340 (Pt 3): 723-728, 1999.
47. Ghosh S, and Karin M. Missing pieces in the NF-kappaB puzzle. Cell 109 Suppl: S81-S96, 2002.
48. Glover RE, Koshkin V, Dunford HB, and Mason RP. The reaction rates of NO with horseradish peroxidase compounds I and II. Nitric Oxide 3: 439-444, 1999.
49. Goligorsky MS, Li H, Brodsky S, and Chen J. Relationships between caveolae and eNOS: everything in proximity and the proximity of everything. Am J Physiol Renal Physiol 283: F1-F10, 2002.
50. Gow AJ, Duran D, Malcolm S, and Ischiropoulos H. Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation. FEBS Lett 385: 63-66, 1996.
51. Grasemann H, Gaston B, Fang K, Paul K, and Ratjen F. Decreased levels of nitrosothiols in the lower airways of patients with cystic fibrosis and normal pulmonary function. J Pediatr 135: 770-772, 1999.
52. Grasemann H, Yandava CN, Storm van's Gravesande K, Deykin A, Pillari A, Ma J, Sonna LA, Lilly C, Stampfer MJ, Israel E, Silverman EK, and Drazen JM. A neuronal NO synthase (NOS1) gene polymorphism is associated with asthma. Biochem Biophys Res Commun 272: 391-394, 2000.
53. Grune T, and Davies KJ. Breakdown of oxidized proteins as a part of secondary antioxidant defenses in mammalian cells. Biofactors 6: 165-172, 1997.
54. Grune T, Reinheckel T, and Davies KJ. Degradation of oxidized proteins in mammalian cells. FASEB J 11: 526-534, 1997.
55. Hammermann R, Hirschmann J, Hey C, Mossner J, Folkerts G, Nijkamp FP, Wessler I, and Racke K. Cationic proteins inhibit L-arginine uptake in rat alveolar macrophages and tracheal epithelial cells. Implications for nitric oxide synthesis. Am J Respir Cell Mol Biol 21: 155-162, 1999.
56. Hancox RJ, Stevens DA, Adcock IM, Barnes PJ, and Taylor DR. Effects of inhaled beta agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma. Thorax 54: 488-492, 1999.
57. Hansel TT, Kharitonov SA, Donnelly LE, Erin EM, Currie MG, Moore WM, Manning PT, Recker DP, and Barnes PJ. A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics. FASEB J 17: 1298-1300, 2003.
58. Hart LA, Krishnan VL, Adcock IM, Barnes PJ, and Chung KF. Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. Am J Respir Crit Care Med 158(5 Pt 1): 1585-1592, 1998.
59. Hebestreit H, Dibbert B, Balatti I, Braun D, Schapowal A, Blaser K, and Simon HU. Disruption of fas receptor signaling by nitric oxide in eosinophils. J Exp Med 187: 415-425, 1998.
60. Hickey MJ, Sharkey KA, Sihota EG, Reinhardt PH, Macmicking JD, Nathan C, and Kubes P. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J 11: 955-964, 1997.
61. Hobbs AJ, and Ignarro LJ. Nitric oxide-cyclic GMP signal transduction system. Methods Enzymol 269: 134-148, 1996.
62. Hoffmann J, Haendeler J, Zeiher AM, and Dimmeler S. TNFalpha and oxLDL reduce protein S-nitrosylation in endothelial cells. J Biol Chem 276: 41383-41387, 2001.
63. Hogg N. Biological chemistry and clinical potential of S-nitrosothiols. Free Radic Biol Med 28: 1478-1486, 2000.
64. Hogg N. The biochemistry and physiology of S-nitrosothiols. Annu Rev Pharmacol Toxicol 42: 585-600, 2002.
65. Hunt JF, Fang K, Malik R, Snyder A, Malhotra N, Platts-Mills TA, and Gaston B. Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med 161(3 Pt 1): 694-699, 2000.
66. Idriss SD, Gudi T, Casteel DE, Kharitonov VG, Pilz RB, and Boss GR. Nitric oxide regulation of gene transcription via soluble guanylate cyclase and type 1 cGMP-dependent protein kinase. J Biol Chem 274: 9489-9493, 1999.
67. Iijima H, Duguet A, Eum SY, Hamid Q, and Eidelman DH. Nitric oxide and protein nitration are eosinophil dependent in allergen-challenged mice. Am J Respir Crit Care Med 163: 1233-1240, 2001.
68. Ischiropoulos H, Zhu L, and Beckman JS. Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys 298: 446-451, 1992.
69. Jaffrey SR, and Snyder SH. The biotin switch method for the detection of S-nitrosylated proteins. Sci STKE 2001: L1, 2001.
70. Jaffrey SR, Erdjument-Bromage H, Ferris CD, Tempst P, and Snyder SH. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat Cell Biol 3: 193-197, 2001.
71. Janssen YM, Soultanakis R, Steece K, Heerdt E, Singh RJ, Joseph J, and Kalyanaraman B. Depletion of nitric oxide causes cell cycle alterations, apoptosis, and oxidative stress in pulmonary cells. Am J Physiol 275(6 Pt 1): L1100-L1109, 1998.
72. Janssen-Heininger YM, Poynter ME, and Baeuerle PA. Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB. Free Radic Biol Med 28: 1317-1327, 2000.
73. Jaspers I, Flescher E, and Chen LC. Ozone-induced IL-8 expression and transcription factor binding in respiratory epithelial cells. Am J Physiol 272(3 Pt 1): L504-L511, 1997.
74. Jatakanon A, Kharitonov S, Lim S, and Barnes PJ. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma. Thorax 54: 108-114, 1999.
75. Ji Y, Akerboom TP, Sies H, and Thomas JA. S-nitrosylation and S-glutathiolation of protein sulfhydryls by S-nitrosoglutathione. Arch Biochem Biophys 362: 67-78, 1999.
76. Jourd'heuil D, Laroux FS, Miles AM, Wink DA, and Grisham MB. Effect of superoxide dismutase on the stability of S-nitrosothiols. Arch Biochem Biophys 361: 323-330, 1999.
77. Kaminsky DA, Mitchell J, Carroll N, James A, Soultanakis R, and Janssen Y. Nitrotyrosine formation in the airways and lung parenchyma of patients with asthma. J Allergy Clin Immunol 104(4 Pt 1): 747-754, 1999.
78. Kanai AJ, Pearce LL, Clemens PR, Birder LA, VanBibber MM, Choi SY, de Groat WC, and Peterson J. Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection. Proc Natl Acad Sci USA 98: 14126-1431, 2001.
79. Karin M, and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 18: 621-663, 2000.
80. Kashiba-Iwatsuki M, Yamaguchi M, and Inoue M. Role of ascorbic acid in the metabolism of S-nitroso-glutathione. FEBS Lett 389: 149-152, 1996.
81. Kenyon NJ, van der Vliet A, Schock BC, Okamoto T, McGrew GM, and Last JA. Susceptibility to ozone-induced acute lung injury in iNOS-deficient mice. Am J Physiol Lung Cell Mol Physiol 282: L540-L545, 2002.
82. Kenyon NJ, Gohil K, and Last JA. Susceptibility to ovalbumin-induced airway inflammation and fibrosis in inducible nitric oxide synthetase-deficient mice: mechanisms and consequences. Toxicol Appl Pharmacol 191: 2-11, 2003.
83. Kharitonov SA, and Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 163: 1693-1722, 2001.
84. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, and Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343: 133-135, 1994.
85. Kim PK, Kwon YG, Chung HT, and Kim YM. Regulation of caspases by nitric oxide. Ann N Y Acad Sci 962: 42-452, 2002.
86. Kleeberger SR, Reddy SP, Zhang LY, Cho HY, and Jedlicka AE. Toll-like receptor 4 mediates ozone-induced murine lung hyperpermeability via inducible nitric oxide synthase. Am J Physiol Lung Cell Mol Physiol 280: L326-L333, 2001.
87. Koarai A, Ichinose M, Sugiura H, Tomaki M, Watanabe M, Yamagata S, Komaki Y, Shirato K, and Hattori T. iNOS depletion completely diminishes reactive nitrogen-species formation after an allergic response. Eur Respir J 20: 609-616, 2002.
88. Kobayashi H, Hataishi R, Mitsufuji H, Tanaka M, Jacobson M, Tomita T, Zapol WM, and Jones RC. Antiinflammatory properties of inducible nitric oxide synthase in acute hyperoxic lung injury. Am J Respir Cell Mol Biol 24: 390-397, 2001.
89. Koh YY, Dupuis R, Pollice M, Albertine KH, Fish JE, and Peters SP. Neutrophils recruited to the lungs of humans by segmental antigen challenge display a reduced chemotactic response to leukotriene B4. Am J Respir Cell Mol Biol 8: 493-499, 1993.
90. Kolodziejski PJ, Musial A, Koo JS, and Eissa NT. Ubiquitination of inducible nitric oxide synthase is required for its degradation. Proc Natl Acad Sci U S A 99: 12315-12320, 2002.
91. Komeima K, Hayashi Y, Naito Y, and Watanabe Y. Inhibition of neuronal nitric-oxide synthase by calcium/ calmodulin-dependent protein kinase 11alpha through Ser847 phosphorylation in NG108-15 neuronal cells. J Biol Chem 275: 28139-28143, 2000.
92. Kone BC, Kuncewicz T, Zhang W, and Yu ZY. Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric oxide. Am J Physiol Renal Physiol 285: F178-F190, 2003.
93. Korn SH, Wouters EF, Vos N, and Janssen-Heininger YM. Cytokine-induced activation of nuclear factor-kappa B is inhibited by hydrogen peroxide through oxidative inactivation of IkappaB kinase. J Biol Chem 276: 35693-35700, 2001.
94. Kupfner JG, Arcaroli JJ, Yum HK, Nadler SG, Yang KY, and Abraham E. Role of NF-kappaB in endotoxemia-induced alterations of lung neutrophil apoptosis. J Immunol 167: 7044-7051, 2001.
95. Lacza Z, Snipes JA, Zhang J, Horvath EM, Figueroa JR, Szabo C, and Busija DW. Mitochondrial nitric oxide synthase is not eNOS, nNOS or iNOS. Free Radic Biol Med 35: 1217-1228, 2003.
96. Lambeth JD, Cheng G, Arnold RS, and Edens WA. Novel homologs of gp91phox. Trends Biochem Sci 25: 459-461, 2000.
97. Lander HM, Hajjar DP, Hempstead BL, Mirza UA, Chait BT, Campbell S, and Quilliam LA. A molecular redox switch on p21(ras). Structural basis for the nitric oxide-p21(ras) interaction. J Biol Chem 272: 4323-4326, 1997.
98. Lang R, Patel D, Morris JJ, Rutschman RL, and Murray PJ. Shaping gene expression in activated and resting primary macrophages by IL-10. J Immunol 169: 2253-2263, 2002.
99. Lawrence T, Gilroy DW, Colville-Nash PR, and Willoughby DA. Possible new role for NF-kappaB in the resolution of inflammation. Nat Med 7: 1291-1297, 2001.
100. Lee J, Ryu H, Ferrante RJ, Morris SM Jr, and Ratan RR. Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox. Proc Natl Acad Sci U S A 100: 4843-4848, 2003.
101. Li M, Carpio DF, Zheng Y, Bruzzo P, Singh V, Ouaaz F, Medzhitov RM, and Beg AA. An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J Immunol 166: 7128-7135, 2001.
102. Li ZW, Chu W, Hu Y, Delhase M, Deerinck T, Ellisman M, Johnson R, and Karin M. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med 189: 1839-1845, 1999.
103. Lin HC, Wang CH, Yu CT, Hwang KS, and Kuo HP. Endogenous nitric oxide inhibits neutrophil adherence to lung epithelial cells to modulate interleukin-8 release. Life Sci 69: 1333-1344, 2001.
104. Liu L, Hausladen A, Zeng M, Que L, Heitman J, and Stamler JS. A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature 410: 490-494, 2001.
105. Maa SH, Wang CH, Liu CY, Lin HC, Huang KH, and Kuo HP. Endogenous nitric oxide downregulates the Bcl-2 expression of eosinophils through mitogen-activated protein kinase in bronchial asthma. J Allergy Clin Immunol 112: 761-767, 2003.
106. Mallozzi C, Di Stasi AM, and Minetti M. Peroxynitrite modulates tyrosine-dependent signal transduction pathway of human erythrocyte band 3. FASEB J 11: 1281-1290, 1997.
107. Mannick JB, and Schonhoff CM. Nitrosylation: the next phosphorylation? Arch Biochem Biophys 408: 1-6, 2002.
108. Marshall HE, and Stamler JS. NO waiting to exhale in asthma. Am J Respir Crit Care Med 161 (3 Pt 1): 685-687, 2000.
109. Marshall HE, and Stamler JS. Inhibition of NF-kappa B by S-nitrosylation. Biochemistry 40: 1688-1693, 2001.
110. Marshall HE, and Stamler JS. Nitrosative stress-induced apoptosis through inhibition of NF-kappa B. J Biol Chem 277: 34223-34228, 2002.
111. Marshall HE, Merchant K, and Stamler JS. Nitrosation and oxidation in the regulation of gene expression. FASEB J 14: 1889-1900, 2000.
112. Mastronarde JG, He B, Monick MM, Mukaida N, Matsushima K, and Hunninghake GW. Induction of interleukin (IL)-8 gene expression by respiratory syncytial virus involves activation of nuclear factor (NF)-kappa B and NF-IL-6. J Infect Dis 174: 262-267, 1996.
113. May MJ, and Ghosh S. Signal transduction through NF-kappa B. Immunol Today 19: 80-88, 1998.
114. May MJ, and Ghosh S. IkappaB kinases: kinsmen with different crafts. Science 284: 271-273, 1999.
115. McDonald KK, Zharikov S, Block ER, and Kilberg MS. A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the "arginine paradox." J Biol Chem 272: 31213-31216, 1997.
116. Mohr S, Stamler JS, and Brune B. Posttranslational modification of glyceraldehyde-3-phosphate dehydrogenase by S-nitrosylation and subsequent NADH attachment. J Biol Chem 271(8): 4209-14, 1996.
117. Mohr S, Hallak H, de Boitte A, Lapetina EG, and Brune B. Nitric oxide-induced S-glutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 274: 9427-9430, 1999.
118. Morrissey BM, Schilling K, Weil JV, Silkoff PE, and Rodman DM. Nitric oxide and protein nitration in the cystic fibrosis airway. Arch Biochem Biophys 406: 33-39, 2002.
119. Moya MP, Gow AJ, McMahon TJ, Toone EJ, Cheifetz IM, Goldberg RN, and Stamler JS. S-Nitrosothiol repletion by an inhaled gas regulates pulmonary function. Proc Natl Acad Sci U S A 98: 5792-5797, 2001.
120. Munder M, Eichmann K, Moran JM, Centeno F, Soler G, and Modolell M. Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J Immunol 163: 3771-3777, 1999.
121. Nathan C. Inducible nitric oxide synthase: what difference does it make? J Clin Invest 100: 2417-2423, 1997.
122. Nikitovic D, and Holmgren A. S-nitrosoglutathione is cleaved by the thioredoxin system with liberation of glutathione and redox regulating nitric oxide. J Biol Chem 271: 19180-19185, 1996.
123. Numanami H, Nelson DK, Hoyt JC, Freels JL, Habib M, Amano J, Haniuda M, Koyama S, and Robbins RA. Peroxynitrite enhances interleukin-10 reduction in the release of neutrophil chemotactic activity. Am J Respir Cell Mol Biol 29: 239-244, 2003.
124. O'Donnell VB, Taylor KB, Parthasarathy S, Kuhn H, Koesling D, Friebe A, Bloodsworth A, Darley-Usmar VM, and Freeman BA. 15-Lipoxygenase catalytically consumes nitric oxide and impairs activation of guanylate cyclase. J Biol Chem 274: 20083-20091, 1999.
125. O'Donnell VB, Coles B, Lewis MJ, Crews BC, Marnett LJ, and Freeman BA. Catalytic consumption of nitric oxide by prostaglandin H synthase-1 regulates platelet function. J Biol Chem 275: 38239-38244, 2000.
126. Okamoto T, Schlegel A, Scherer PE, and Lisanti MP. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem 273: 5419-5422, 1998.
127. Okamoto T, Gohil K, Finkelstein EI, Bove P, Akaike T, and van der Vliet A. Multiple contributing roles for NOS2 in LPS-induced acute airway inflammation in mice. Am J Physiol Lung Cell Mol Physiol, 286: L198-L209, 2004.
128. Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18: 6853-6866, 1999.
129. Peng HB, Libby P, and Liao JK. Induction and stabilization of 1 kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J Biol Chem 270: 14214-14219, 1995.
130. Poynter ME, Irvin CG, and Janssen-Heininger YM. Rapid activation of nuclear factor-kappaB in airway epithelium in a murine model of allergic airway inflammation. Am J Pathol 160: 1325-1334, 2002.
131. Pritchard KA Jr, Ackerman AW, Gross ER, Stepp DW, Shi Y, Fontana JT, Baker JE, and Sessa WC. Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric-oxide synthase. J Biol Chem 216: 17621-17634, 2001.
132. Raychaudhuri B, Dweik R, Connors MJ, Buhrow L, Malur A, Drazba J, Arroliga AC, Erzurum SC, Kavuru MS, and Thomassen MJ. Nitric oxide blocks nuclear factor-kappaB activation in alveolar macrophages. Am J Respir Cell Mol Biol 21: 311-316, 1999.
133. Richardson G, and Benjamin N. Potential therapeutic uses for S-nitrosothiols. Clin Sci (Lond) 102: 99-105, 2002.
134. Rothwarf DM, Zandi E, Natoli G, and Karin M. IKKgamma is an essential regulatory subunit of the IkappaB kinase complex. Nature 395: 297-300, 1998.
135. Sadeghi-Hashjin G, Folkerts G, Henricks PA, Verheyen AK, van der Linde HJ, van Ark I, Coene A, and Nijkamp FP. Peroxynitrite induces airway hyperresponsiveness in guinea pigs in vitro and in vivo. Am J Respir Crit Care Med 153: 1697-1701, 1996.
136. Sato E, Simpson KL, Grisham MB, Koyama S, and Robbins RA. Reactive nitrogen and oxygen species attenuate interleukin- 8-induced neutrophil chemotactic activity in vitro. J Biol Chem 215: 10826-10830, 2000.
137. Schonhoff CM, Gaston B, and Mannick JB. Nitrosylation of cytochrome c during apoptosis. J Biol Chem 278: 18265-18270, 2003.
138. Senftleben U, Cao Y, Xiao G, Greten FR, Krahn G, Bonizzi G, Chen Y, Hu Y, Fong A, Sun SC, and Karin M. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293: 1495-1499, 2001.
139. Sexton DJ, Muruganandam A, McKenney DJ, and Mutus B. Visible light photochemical release of nitric oxide from S-nitrosoglutathione: potential photochemotherapeutic applications. Photochem Photobiol 59: 463-467, 1994.
140. Simon DI, Mullins ME, Jia L, Gaston B, Singel DJ, and Stamler JS. Polynitrosylated proteins: characterization, bioactivity, and functional consequences. Proc Natl Acad Sci U S A 93: 4736-4741, 1996.
141. Sittipunt C, Steinberg KP, Ruzinski JT, Myles C, Zhu S, Goodman RB, Hudson LD, Matalon S, and Martin TR. Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 163: 503-510, 2001.
142. Snyder AH, McPherson ME, Hunt JF, Johnson M, Stamler JS, and Gaston B. Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis. Am J Respir Crit Care Med 165: 922-926, 2002.
143. Souza, JM, Choi I, Chen Q, Weisse M, Daikhin E, Yudkoff M, Obin M, Ara J, Horwitz J, and Ischiropoulos H. Proteolytic degradation of tyrosine nitrated proteins. Arch Biochem Biophys 380: 360-366, 2000.
144. Spector EB, Rice SC, Moedjono S, Bernard B, and Cederbaum SD. Biochemical properties of arginase in human adult and fetal tissues. Biochem Med 28: 165-175, 1982.
145. Spencer NY, Zeng H, Patel RP, and Hogg N. Reaction of S-nitrosoglutathione with the heme group of deoxyhemoglobin. J Biol Chem 275: 36562-36567, 2000.
146. Stacey MA, Sun G, Vassalli G, Marini M, Bellini A, and Mattoli S. The allergen Der p1 induces NF-kappaB activation through interference with IkappaB alpha function in asthmatic bronchial epithelial cells. Biochem Biophys Res Commun 236: 522-526, 1997.
147. Stamler, JS, Toone EJ, Lipton SA, and Sucher NJ. (S)NO signals: translocation, regulation, and a consensus motif. Neuron 18(5): 691-696, 1997.
148. Stamler JS, Lamas S, and Fang FC. Nitrosylation the prototypic redox-based signaling mechanism. Cell 106: 675-683, 2001.
149. Steudel W, Kirmse M, Weimann J, Ullrich R, Hromi J, and Zapol WM. Exhaled nitric oxide production by nitric oxide synthase-deficient mice. Am J Respir Crit Care Med 162(4 Pt 1): 1262-1267, 2000.
150. Thomassen MJ, and Kavuru MS. Human alveolar macrophages and monocytes as a source and target for nitric oxide. Int Immunopharmacol 1: 1479-1490, 2001.
151. Torok NJ, Higuchi H, Bronk S, and Gores GJ. Nitric oxide inhibits apoptosis downstream of cytochrome C release by nitrosylating caspase 9. Cancer Res 62: 1648-1653, 2002.
152. Torres J, Sharpe MA, Rosquist A, Cooper CE, and Wilson MT. Cytochrome c oxidase rapidly metabolises nitric oxide to nitrite. FEBS Lett 475: 263-266, 2000.
153. Trujillo M, Alvarez MN, Peluffo G, Freeman BA, and Radi R. Xanthine oxidase-mediated decomposition of S-nitrosothiols. J Biol Chem 273: 7828-7834, 1998.
154. van der Vliet A, Eiserich JP, Halliwell B, and Cross CE. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity. J Biol Chem 272: 7617-7625, 1997.
155. van der Vliet A, Hoen PA, Wong PS, Bast A, and Cross CE. Formation of S-nitrosothiols via direct nucleophilic nitrosation of thiols by peroxynitrite with elimination of hydrogen peroxide. J Biol Chem 273: 30255-30262, 1998.
156. Van's Gravesande KS, Wechsler ME, Grasemann H, Silverman ES, Le L, Palmer LJ, and Drazen JM. Association of a missense mutation in the NOS3 gene with exhaled nitric oxide levels. Am J Respir Crit Care Med 168: 228-231, 2003.
157. Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BS, Karoui H, Tordo P, and Pritchard KA Jr. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci U S A 95: 9220-9225, 1998.
158. Wu W, Chen Y, and Hazen SL. Eosinophil peroxidase nitrates protein tyrosyl residues. Implications for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders. J Biol Chem 274: 25933-25944, 1999.
159. Xia Y, and Zweier JL. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci USA 94: 6954-6958, 1997.
160. Xiao G, Harhaj EW, and Sun SC. NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol Cell 7: 401-409, 2001.
161. Xiong Y, Karupiah G, Hogan SR, Foster PS, and Ramsay AJ. Inhibition of allergic airway inflammation in mice lacking nitric oxide synthase 2. J Immunol 162: 445-452, 1999.
162. Yamamoto Y, Verma UN, Prajapati S, Kwak YT, and Gaynor RB. Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression. Nature 423: 655-659, 2003.
163. Yates DH, Kharitonov SA, Thomas PS, and Barnes PJ. Endogenous nitric oxide is decreased in asthmatic patients by an inhibitor of inducible nitric oxide synthase. Am J Respir Crit Care Med 154: 247-250, 1996.
164. Zaman K, McPherson M, Vaughan J, Hunt J, Mendes F, Gaston B, and Palmer LA. S-Nitrosoglutathione increases cystic fibrosis transmembrane regulator maturation. Biochem Biophys Res Commun 284: 65-70, 2001.
165. Zandi E, and Karin M. Bridging the gap: composition, regulation, and physiological function of the IkappaB kinase complex. Mol Cell Biol 19: 4547-4551, 1999.
166. Zech B, Kohl R, von Knethen A, and Brune B. Nitric oxide donors inhibit formation of the Apaf-1/caspase-9 apoptosome and activation of caspases. Biochem J 371(Pt 3): 1055-1064, 2003.
167. Zeng H, Spencer NY, and Hogg N. Metabolism of S-nitrosoglutathione by endothelial cells. Am J Physiol Heart Circ Physiol 281: H432-H439, 2001.
168. Zhu S, Ware LB, Geiser T, Matthay MA, and Matalon S. Increased levels of
169. Zimmermann N, King NE, Laporte J, Yang M, Mishra A, Pope SM, Muntel EE, Witte DP, Pegg AA, Foster PS, Hamid Q, and Rothenberg ME. Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest 111: 1863-1874, 2003.
170. Zweier JL, Samouilov A, and Kuppusamy P. Non-enzymatic nitric oxide synthesis in biological systems. Biochim Biophys Acta 1411: 250-262, 1999.